Tweet
NEW ORLEANS, LA?During the 2013-2014 A/H1N1 dominant flu season, Fluzone High-Dose vaccine reduced the risk of all-cause hospitalization as well as hospitalization for respiratory conditions among long-term care residents, compared with Fluzone standard-dose vaccine, investigators reported at IDWeek 2016.
Noting that response to the flu vaccine declines with age, lead study author Stefan Gravenstein, MD, MPH, of Warren Alpert Medical School, Brown University, in Providence, RI, and colleagues sought to determine whether or not a more immunogenic vaccine would reduce hospitalizations among nursing home residents.
Noting that response to the flu vaccine declines with age, lead study author Stefan Gravenstein, MD, MPH, of Warren Alpert Medical School, Brown University, in Providence, RI, and colleagues sought to determine whether or not a more immunogenic vaccine would reduce hospitalizations among nursing home residents.